本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Astria Therapeutics Inc

7.36
+0.06000.82%
盘后7.360.00000.00%17:18 EDT
成交量:37.61万
成交额:277.28万
市值:4.15亿
市盈率:-3.65
高:7.48
开:7.34
低:7.19
收:7.30
52周最高:12.52
52周最低:3.56
股本:5,643.49万
流通股本:3,452.14万
量比:1.21
换手率:1.09%
股息:- -
股息率:- -
每股收益(TTM):-2.0170
每股收益(LYR):-1.6784
净资产收益率:-38.49%
总资产收益率:-25.28%
市净率:1.43
市盈率(LYR):-4.39

数据加载中...

2024/05/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/09

重要事件披露

Form 8-K - Current report
2024/04/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/25

重要事件披露

Form 8-K - Current report
2024/03/05

重要事件披露

Form 8-K - Current report
2024/03/04

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/12

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/05

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/31

重要事件披露

Form 8-K - Current report
2024/01/30

重要事件披露

Form 8-K - Current report
2024/01/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/16

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/05

重要事件披露

Form 8-K - Current report
2024/01/03

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/12/29

SEC问询函

Form CORRESP - Correspondence